logo

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Marksans Pharma Share Price

MARKSANS

₹291.35

-7.70(-2.57%)
20th Nov 2026 | 3:28 PM
NSE : MARKSANS

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Marksans Pharma Share Price Today

As of 20-11-2026 18:05, Marksans Pharma Ltd. share price today is ₹0, with a change of ₹-299.05 (-100.00%) from the previous close of ₹299.05. The stock opened at ₹296 and traded between ₹288.4 and ₹297.2, with a total traded volume of 907829 shares. The company has a market capitalization of ₹13553.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹350.95 and ₹155, respectively.

Marksans Pharma Ltd. valuation metrics include a P/E ratio of 24.2, EPS of ₹9.22, and book value of ₹4.30. Profitability indicators show ROE of 13.83% along with a dividend yield of 0.3%. Marksans Pharma Ltd. has reported revenue of ₹3391.51 Cr and net profit of ₹559.81 Cr.

Marksans Pharma Ltd. technical indicators include Day RSI at 44.5, Day MFI at 39.72, Day ADX at 13.9. Additional indicators include Commodity Channel Index (CCI) at -112.5 and Williams %R at -77.7. Momentum indicators show Day MACD at -2.4, Day MACD Signal Line at -1.84, DayATR at 12.68. Rate of Change indicators for Marksans Pharma Ltd. include ROC125 at 38.34 and ROC21 at 0.3.

Exponential moving averages include EMA5 at ₹303, EMA10 at ₹305.6, EMA12 at ₹306.1, EMA20 at ₹307.5, EMA26 at ₹308.5, EMA50 at ₹308.6, EMA100 at ₹295.1, EMA200 at ₹268. Simple moving averages include SMA5 at ₹305.5, SMA10 at ₹307, SMA20 at ₹306.2, SMA30 at ₹306.8, SMA50 at ₹315.9, SMA100 at ₹301.9, SMA150 at ₹275, SMA200 at ₹249.6.

Support levels for Marksans Pharma are placed at First Support ₹293.10, Second Support ₹287.15, Third Support ₹283.75. Resistance levels are seen at First Resistance ₹302.45, Second Resistance ₹305.85, Third Resistance ₹311.80. Marksans Pharma Ltd. shareholding pattern shows promoter holding at 43.87%, FII holding at 19.06%, DII holding at 0%, public holding at 31.53%.

Marksans Pharma Performance

Price Movement

₹291.35

₹288.40

₹297.20

↘ Today's Low↗ Today's High

1 Year Performance

₹291.35

₹155.00

₹350.95

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹297.20
Low₹288.40
Open at₹296.00
Prev Close₹299.05
Volumes9.08 L
Avg Price₹291.86
Lower Circuit₹239.25
Upper Circuit₹358.85

Historical Performance

3M High₹350.95
3M Low₹282.70
1 Yr High₹350.95
1 Yr Low₹155.00
3 Yr High₹358.70
3 Yr Low₹130.00
5 Yr High₹358.70
5 Yr Low₹38.60

Marksans Pharma Fundamentals

Market Cap
High in industry
13,553.50 Cr.
PE Ratio (TTM)
Below industry Median
24.20
Dividend Yield
Below industry Median
0.30
Net Profit TTM
59.2% incr over last year
559.81
Net Profit Growth
59.2% incr over last year
559.81
PEG Ratio
Above industry Median
0.40
ROE
10% decr over last year
13.83
Operating Revenue TTM
3,391.51
Operating Revenue Growth
24.2% incr over last year
Book Value
Above industry Median
4.30
MFI
MFI is mid-range
39.72
RSI
RSI is mid-range
44.50
EPS (TTM)
9.22
Debt to Equity
0.01
Face Value
1
Operating Profit Margin Qtr.
19.81
Operating Profit Qtr.
214.29
Net Profit Qtr.
141.31
Operating Revenue Qtr.
940.17
PB Ratio
4.30

Marksans Pharma Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Sep 2026
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Total Revenue313.80321.19361.57339.73320.44
Operating Expense261.45239.08255.58264.28248.37
Operating Profit52.3682.10105.9975.4472.08
Depreciation9.058.788.768.838.46
Interest0.340.340.350.360.32
Tax14.6721.4232.4421.2021.69
Net Profit85.5469.0491.9260.9199.81

Marksans Pharma Technicals

Marksans Pharma Ltd. EMA & SMA

₹291.35

-3.15 (-1.07%)

↗ Bullish Moving Average

4

↘ Bearish Moving Average

12

Day EMA5 ₹303
Day EMA10 ₹305.6
Day EMA12 ₹306.1
Day EMA20 ₹307.5
Day EMA26 ₹308.5
Day EMA50 ₹308.6
Day EMA100 ₹295.1
Day EMA200 ₹268

Marksans Pharma Support and Resistance

Resistance

First Resistance₹302.45
Second Resistance₹305.85
Third Resistance₹311.80

Support

First Support₹293.10
Second Support₹287.15
Third Support₹283.75

Technical Indicators

Day RSI44.50
Day MFI39.72
Day ADX13.90
Day Commodity Channel Index-112.50
William-77.70
Day MACD-2.40
Day MACD Signal Line-1.84
Day ATR12.68
Day ROC12538.34
Day ROC210.30

Marksans Pharma Shareholding Pattern

Held ByJun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoter43.943.943.943.943.943.9
FII19.916.98.116.817.519.1
DII5.55.35.96.56.25.5
Public30.733.942.132.832.531.5

Marksans Pharma Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day2.87 L7.8 L36.80%
Week5.76 L12.69 L45.35%
1 Month6.63 L15.87 L41.77%
6 Month9.69 L32.86 L29.49%

Marksans Pharma SWOT Analysis

Strengths19
Weakness4
Opportunity1
Threats2

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Newly Affordable Stocks with Good Financials and Durability (subscription)

Consistent high performing stocks over Five Years

Mid-range Performer (DVM)

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Insiders bought stocks

Marksans Pharma Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
20 Aug, 20260.9FINAL20 Aug, 2026Equity Share
01 Aug, 20250.8FINAL01 Aug, 2025Equity Share
17 Sep, 20240.6FINAL17 Sep, 2024Equity Share
07 Jun, 20230.5FINAL07 Jun, 2023Equity Share
19 Aug, 20220.25FINALEquity Share
15 Sep, 20210.25FINALEquity Share
22 Sep, 20200.1FINALEquity Share
19 Sep, 20190.05FINALEquity Share
19 Sep, 20180.05FINALEquity Share
19 Sep, 20170.05FINALEquity Share

Marksans Pharma Stock Comparison

Financials
Price (₹)₹1,605.80₹2,245₹1,192.90₹190.10₹1,314₹987
% Change0.06%0.37%-1.58%-1.28%-1.13%-3.67%
Revenue TTM (₹ Cr)-₹1,559.11₹709.64₹1,931.62₹3,329.63₹2,161.16
Net Profit TTM (₹ Cr)-₹207.02₹188.34₹1,635.75₹707.54₹256.69
PE TTM-66.2072.703.8025.9036.20
1 Year Return62.43110.92104.447.31-17.9744.66
ROCE14.9731.5424.22112.8916.0410.79
Summarize with AI
Google GeminiChatGPTPerplexity AIAnthropic AIGrok AI

FAQ's on MARKSANS

Desktop BannerMobile Banner

Invest Anytime, Anywhere

Get it on Google PlayGet it on App Store

Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy